AARDEX Group is a leader in digital solutions for medication adherence, leveraging its proprietary MEMS® Adherence Software (MEMS AS®) to provide accurate, data-driven analytics for clinical trials. Founded in 1987, the company is based in Liege Science Park, Belgium, and employs 26 individuals. AARDEX Group is dedicated to revolutionizing medication adherence through technology and data, aiming to empower patients and improve clinical trial outcomes.
The company's mission is to lead the charge in medication adherence by using data and technology to transform clinical trials. AARDEX Group's innovative approach and commitment to continuous improvement set it apart in the industry. Their ecosystem is designed to deliver comprehensive adherence analytics across various drug administration forms.
AARDEX Group's focus on innovation and its mission to revolutionize medication adherence make it a key player in the clinical trials sector. The company's dedication to pushing the boundaries of what's possible in the world of clinical trials underscores its commitment to excellence and patient empowerment.
B2B professionals should contact AARDEX Group for cutting-edge medication adherence solutions that enhance clinical trial outcomes. Their innovative technology and data-driven approach provide a competitive edge in the clinical trials sector.
Sales teams selling clinical trial solutions, recruiters seeking roles in digital health innovation, and partners offering technology integration services should reach out to AARDEX Group.
Get qualified leads in 10 minutes. Research prospects, find decision makers, and monitor for the perfect moment to reach out.
Last verified: February 2, 2026
Connect with AARDEX Group